Showing results (11-20 of 190) with videos related to
Sort By:
Pageof 19
Drug Intelligence & Clinical Pharmacy|October 1, 1986
Monitoring vancomycin therapyM J Rybak, S C BoikeAntimicrobial Agents and Chemotherapy|March 1, 1996
Comparison of methodologies for synergism testing of drug combinations against resistant strains of Pseudomonas aeruginosaD M Cappelletty, M J RybakAntimicrobial Agents and Chemotherapy|June 20, 2000
In vitro activities of daptomycin, arbekacin, vancomycin, and gentamicin alone and/or in combination against glycopeptide intermediate-resistant Staphylococcus aureus in an infection modelR L Akins, M J RybakAntimicrobial Agents and Chemotherapy|July 1, 1995
Pharmacodynamics of RP 59500 alone and in combination with vancomycin against Staphylococcus aureus in an in vitro-infected fibrin clot modelS L Kang, M J RybakAntimicrobial Agents and Chemotherapy|March 1, 1993
Teicoplanin and daptomycin bactericidal activities in the presence of albumin or serum under controlled conditions of pH and ionized calciumK C Lamp, M J RybakThe Journal of Antimicrobial Chemotherapy|May 1, 1997
In-vitro bactericidal activity of quinupristin/dalfopristin alone and in combination against resistant strains of Enterococcus species and Staphylococcus aureusS L Kang, M J RybakDrug Intelligence & Clinical Pharmacy|November 1, 1986
Hematological effects associated with beta-lactam useL M Babiak, M J RybakAntimicrobial Agents and Chemotherapy|September 16, 1998
Pharmacodynamic analysis of the activity of quinupristin-dalfopristin against vancomycin-resistant Enterococcus faecium with differing MBCs via time-kill-curve and postantibiotic effect methodsJ R Aeschlimann, M J RybakPharmacotherapy|June 10, 1998
The pharmacologic and bacteriologic properties of oxazolidinones, a new class of synthetic antimicrobialsL D Dresser, M J RybakPageof 19